Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Marinus Pharma CS (MRNS)

1.52 -0.02 (-1.30%)

4/25/2017  12:06pm

Open:

1.53

Pre. Close:

1.54

High:

1.58

Low:

1.52

Volume:

150,453

Market Cap:

32.74M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.59 - 1.62

1.62 - 1.66

Low:

1.34 - 1.36

1.36 - 1.4

Close:

1.48 - 1.53

1.53 - 1.6

Technical analysis  (as of: 2017-04-25 12:06:53 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 1.89     One year: 2.14

Support:

Support1: 1.28    Support2: 1.06

Resistance:

Resistance1: 1.62    Resistance2: 1.83

Pivot:

1.49

Moving Averages:

MA(5): 1.49     MA(20): 1.52

MA(100): 1.28     MA(250): 1.88

MACD:

MACD(12,26):     Signal(12,26,9):

%K %D:

%K(14,3): 47.29     %D(3): 39.72

RSI:

RSI(14): 54.51

52-Week:

High: 6.45  Low: 0.82  Change(%): -73.5

Average Vol(K):

3-Month: 713  10-Days 378

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
MRNS has closed below upper band by 33.9%. Bollinger Bands are 2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 11 Apr 2017 11:26:15 GMT
Dr. Lorianne K. Masuoka Joins Marinus Pharmaceuticals as Chief Medical Officer

Tue, 24 Jan 2017 15:00:00 GMT
Marinus Pharmaceuticals Inc (NASDAQ:MRNS) Is Trying To Clean Up In Epilepsy

Wed, 05 Apr 2017 12:56:15 GMT
Ligand Enters Commercial License and Supply Agreements with Marinus ...

Mon, 13 Jun 2016 13:41:15 GMT
Why Marinus Pharmaceuticals Shares Are Sliding

Thu, 29 Sep 2016 15:33:07 GMT
Stock Update (NASDAQ:MRNS): Here's Why Marinus Pharmaceuticals Inc Are Down 25%

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

21.54

Shares Float (M)

15.60

% Held by Insiders

44.31

% Held by Institutions

44.90

Shares Short (K)

2510

Shares Short Prior Month (K)

2350

Stock Financials

EPS

-1.470

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

1.090

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-38.8

Return on Equity (ttm)

-83.8

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.310

Qtrly Earnings Growth

Operating Cash Flow (M)

-24.77

Levered Free Cash Flow (M)

-14.83

FoxReading.com

Valuation

P/E

-1.05

P/E Growth Ratio

P/BV

1.41

P/S

P/CF

-1.34

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.